UK markets close in 4 hours 27 minutes

Humana Inc. (HUM)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
426.21+0.72 (+0.17%)
At close: 4:04PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close425.49
Open423.01
Bid0.00 x 1200
Ask0.00 x 800
Day's range420.01 - 428.17
52-week range370.22 - 475.44
Volume905,098
Avg. volume818,693
Market cap54.77B
Beta (5Y monthly)0.89
PE ratio (TTM)22.54
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.80 (0.66%)
Ex-dividend date29 Jun 2021
1y target estN/A
  • Humana's (HUM) Q2 Earnings Surpass Estimates, Tumble Y/Y
    Zacks

    Humana's (HUM) Q2 Earnings Surpass Estimates, Tumble Y/Y

    Humana's (HUM) second-quarter earnings gain from higher revenues and strong performances by its Retail and Healthcare Services segments.

  • Reuters

    Humana warns of hit to 2021 profit due to COVID-19 uncertainty

    Health insurer spending on medical claims fell during the height of the pandemic as patients and hospitals postponed non-urgent surgeries to soften the impact on the healthcare system, but benefits from deferred care were offset by higher spending on COVID-19 testing and treatment. "We do expect, given that the country has been largely open, our population is largely vaccinated, that we will see non-COVID utilization start to normalize," Chief Financial Officer Susan Diamond said. Humana said it has seen COVID-19 testing and treatment costs come down faster than initially expected in the first half of the year, but non-coronavirus outpatient costs were rebounding faster than anticipated.

  • Humana (HUM) Q2 Earnings and Revenues Surpass Estimates
    Zacks

    Humana (HUM) Q2 Earnings and Revenues Surpass Estimates

    Humana (HUM) delivered earnings and revenue surprises of 0.44% and 0.67%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?